Evidence map›Paper›PMID 28209993›Full record

ArticleScientific reports2017

Suppression of TAK1 pathway by shear stress counteracts the inflammatory endothelial cell phenotype induced by oxidative stress and TGF-β1.

Ee Soo Lee, Llorenç Solé Boldo, Bernadette O Fernandez, Martin Feelisch, Martin C Harmsen

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Peripheral vascular remodeling during ischemia.Frontiers in pharmacology · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Ee Soo LeeUniversity of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, NL-9713 GZ, The Netherlands.
Llorenç Solé BoldoUniversity of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, NL-9713 GZ, The Netherlands.
Bernadette O FernandezUniversity of Southampton, Southampton General Hospital, Faculty of Medicine, Clinical and Experimental Sciences, Southampton, SO166YD, United Kingdom.
Martin FeelischUniversity of Southampton, Southampton General Hospital, Faculty of Medicine, Clinical and Experimental Sciences, Southampton, SO166YD, United Kingdom.
Martin C HarmsenUniversity of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, NL-9713 GZ, The Netherlands.
University of Groningen · NLSouthampton General Hospital · GBUniversity Medical Center Groningen · NLUniversity of Southampton · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endothelial dysfunction is characterised by aberrant redox signalling and an inflammatory phenotype. Shear stress antagonises endothelial dysfunction by increasing nitric oxide formation, activating anti-inflammatory pathways and suppressing inflammatory pathways. The TAK1 (MAP3K7) is a key mediator of inflammation and non-canonical TGF-β signalling. While the individual roles of TAK1, ERK5 (MAPK7) and TGF-β pathways in endothelial cell regulation are well characterised, an integrative understanding of the orchestration of these pathways and their crosstalk with the redox system under shear stress is lacking. We hypothesised that shear stress counteracts the inflammatory effects of oxidative stress and TGF-β1 on endothelial cells by restoring redox balance and repressing the TAK1 pathway. Using human umbilical vein endothelial cells, we here show that TGF-β1 aggravates oxidative stress-mediated inflammatory activation and that shear stress activates ERK5 signalling while attenuating TGF-β signalling. ERK5 activation restores redox balance, but fails to repress the inflammatory effect of TGF-β1 which is suppressed upon TAK1 inhibition. In conclusion, shear stress counteracts endothelial dysfunction by suppressing the pro-inflammatory non-canonical TGF-β pathway and by activating the ERK5 pathway which restores redox signalling. We propose that a pharmacological compound that abates TGF-β signalling and enhances ERK5 signalling may be useful to counteract endothelial dysfunction.

Indexed as

Oxidative StressPhenotypeShear StrengthSignal TransductionAnimalsBiomarkersEndothelial CellsHumansHuman Umbilical Vein Endothelial CellsInflammation MediatorsMAP Kinase Kinase Kinase 7MAP Kinase Kinase KinasesMitochondriaMitogen-Activated Protein Kinase 7Models, BiologicalNF-kappa BBiomarkersInflammation MediatorsMAP Kinase Kinase Kinase 7MAP Kinase Kinase KinasesMitogen-Activated Protein Kinase 7NF-kappa BReactive Oxygen SpeciesTransforming Growth Factor beta1

Identifiers

PMID28209993
PMCPMC5314358
OpenAlexW2588949028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.